Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 08 04:00PM ET
2.42
Dollar change
-0.13
Percentage change
-5.10
%
IndexRUT P/E- EPS (ttm)-1.71 Insider Own13.83% Shs Outstand98.63M Perf Week-0.41%
Market Cap275.59M Forward P/E- EPS next Y-1.65 Insider Trans-0.00% Shs Float98.13M Perf Month-17.69%
Income-175.72M PEG- EPS next Q-0.42 Inst Own93.11% Short Float16.37% Perf Quarter-27.33%
Sales12.32M P/S22.37 EPS this Y-0.05% Inst Trans-4.75% Short Ratio12.35 Perf Half Y-40.69%
Book/sh3.49 P/B0.69 EPS next Y-0.81% ROA-31.56% Short Interest16.06M Perf Year3.86%
Cash/sh2.68 P/C0.90 EPS next 5Y- ROE-42.10% 52W Range1.91 - 8.83 Perf YTD-35.29%
Dividend Est.- P/FCF- EPS past 5Y-6.65% ROI-35.80% 52W High-72.59% Beta1.88
Dividend TTM- Quick Ratio9.18 Sales past 5Y87.14% Gross Margin-55.61% 52W Low26.70% ATR (14)0.24
Dividend Ex-Date- Current Ratio9.18 EPS Y/Y TTM21.30% Oper. Margin-1587.28% RSI (14)36.71 Volatility12.66% 8.16%
Employees181 Debt/Eq0.25 Sales Y/Y TTM-89.67% Profit Margin-1426.67% Recom2.65 Target Price6.62
Option/ShortYes / Yes LT Debt/Eq0.24 EPS Q/Q38.99% Payout- Rel Volume1.49 Prev Close2.55
Sales Surprise410.52% EPS Surprise28.80% Sales Q/Q625.83% EarningsAug 13 AMC Avg Volume1.30M Price2.42
SMA20-14.59% SMA50-25.33% SMA200-47.03% Trades Volume1,943,330 Change-5.10%
Date Action Analyst Rating Change Price Target Change
Jun-17-24Upgrade Piper Sandler Neutral → Overweight $4 → $6
Mar-27-23Resumed Wells Fargo Equal Weight $6
Jan-24-23Downgrade H.C. Wainwright Buy → Neutral $115 → $7
Jan-06-23Downgrade Wedbush Outperform → Neutral $42 → $7
Jan-06-23Downgrade Truist Buy → Hold $46 → $7
Jan-06-23Downgrade Stifel Buy → Hold $107 → $5.30
Jan-06-23Downgrade Piper Sandler Overweight → Neutral $71 → $12
Jan-06-23Downgrade Cowen Outperform → Market Perform
Jan-06-23Downgrade BofA Securities Buy → Underperform $72 → $4
Jan-06-23Downgrade BMO Capital Markets Outperform → Market Perform $20 → $7
Today 04:01PM
Nov-04-24 04:01PM
Oct-02-24 04:01PM
Sep-12-24 04:01PM
11:30AM
12:00PM Loading…
Aug-16-24 12:00PM
Aug-13-24 05:25PM
04:25PM
04:05PM
Aug-02-24 04:01PM
Jul-31-24 08:00AM
Jul-21-24 05:37AM
Jul-02-24 04:01PM
Jun-04-24 04:01PM
May-29-24 04:01PM
10:48AM Loading…
May-13-24 10:48AM
May-10-24 02:50PM
10:36AM
08:22AM
May-09-24 08:58PM
05:25PM
04:21PM
04:01PM
08:30AM
May-06-24 08:00AM
May-03-24 04:30PM
Apr-22-24 04:30PM
Apr-06-24 02:17AM
Apr-04-24 11:30PM
Apr-03-24 08:00AM
04:01PM Loading…
Apr-02-24 04:01PM
Mar-27-24 11:30AM
Mar-19-24 08:44AM
Mar-05-24 04:01PM
Mar-01-24 08:09AM
08:00AM
Feb-27-24 09:16AM
08:07AM
Feb-26-24 05:10PM
04:35PM
04:08PM
04:01PM
Feb-21-24 09:21AM
Feb-19-24 10:00AM
Feb-15-24 08:00AM
Feb-02-24 04:01PM
Jan-30-24 07:54AM
Jan-29-24 02:53PM
Jan-08-24 08:00AM
Dec-22-23 12:00PM
Dec-18-23 02:58PM
Dec-13-23 05:00PM
Dec-08-23 11:30AM
Nov-09-23 01:18PM
Nov-08-23 06:18PM
04:08PM
04:01PM
Oct-25-23 08:00AM
Sep-15-23 06:01AM
Sep-07-23 11:30AM
Aug-31-23 08:00AM
Aug-29-23 07:30AM
Aug-09-23 12:12PM
11:04AM
Aug-08-23 05:15PM
04:11PM
04:01PM
Jul-28-23 08:00AM
Jul-22-23 08:35AM
Jul-01-23 10:33AM
Jun-16-23 03:53PM
Jun-14-23 06:42AM
Jun-08-23 11:30AM
Jun-07-23 11:30AM
Jun-04-23 08:27AM
Jun-02-23 11:31AM
May-31-23 08:00AM
May-25-23 10:49AM
May-08-23 06:05AM
May-04-23 11:59AM
11:22AM
May-03-23 05:15PM
04:11PM
04:01PM
12:00PM
Apr-27-23 10:03AM
Apr-26-23 10:02AM
Apr-24-23 08:00AM
Apr-12-23 07:20AM
Mar-30-23 11:30AM
Mar-27-23 09:00AM
Mar-03-23 04:01PM
Mar-02-23 09:18PM
05:30AM
Mar-01-23 09:59AM
Feb-28-23 05:15PM
04:01PM
Feb-27-23 09:31AM
Feb-13-23 08:00AM
Feb-06-23 09:55AM
Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates. The company was founded by Philip Beachy, Sheng Ding, Rudolf Jaenisch, Randall T. Moon, Michael Rudnicki, David Scadden, Leonard Zon, Alexander Rives, Scott Wolchko, and John D. Mendlein on April 27, 2007 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Xu YuanDirectorAug 06 '24Sale4.236332,6788,669Aug 07 04:01 PM
Xu YuanDirectorAug 06 '24Proposed Sale4.236332,678Aug 06 10:34 AM
Dulac Edward J IIIChief Financial OfficerMar 04 '24Sale7.772,44719,013101,479Mar 05 04:24 PM
Dulac Edward J IIIChief Financial OfficerJan 29 '24Sale5.001,8499,245103,926Jan 30 04:01 PM
TAHL CINDYGeneral Counsel and SecretaryJan 09 '24Sale4.3710,87447,519142,361Jan 10 04:30 PM
Valamehr BahramChief R&D OfficerJan 09 '24Sale4.3811,27149,367158,069Jan 10 04:30 PM
Wolchko J ScottPresident and CEOJan 09 '24Sale4.3714,39162,889371,248Jan 10 04:29 PM
Dulac Edward J IIIChief Financial OfficerJan 09 '24Sale4.377,02830,712105,775Jan 10 04:29 PM
Dulac Edward J IIIChief Financial OfficerJan 02 '24Sale3.665,18218,966112,803Jan 03 04:03 PM
Redmile Group, LLCDirectorDec 26 '23Buy3.7244,630166,02413,180,388Dec 28 09:30 PM
Dulac Edward J IIIChief Financial OfficerDec 18 '23Sale3.501,5855,548117,985Dec 19 04:01 PM
TAHL CINDYGeneral Counsel and SecretaryNov 09 '23Sale2.4024,36358,471153,235Nov 13 04:01 PM